NDC 71335-1858 – BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-1858

Product details

Brand name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Generic name
BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA209069
Marketed since
January 22, 2021
Listing expires
December 31, 2026
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE →

Package NDC codes (10)

Package NDCDescriptionSince
71335-1858-042 TABLET in 1 BOTTLE, PLASTIC (71335-1858-0)Feb 14, 2022
71335-1858-130 TABLET in 1 BOTTLE, PLASTIC (71335-1858-1)May 7, 2021
71335-1858-260 TABLET in 1 BOTTLE, PLASTIC (71335-1858-2)Jun 8, 2021
71335-1858-390 TABLET in 1 BOTTLE, PLASTIC (71335-1858-3)Feb 14, 2022
71335-1858-4120 TABLET in 1 BOTTLE, PLASTIC (71335-1858-4)Feb 14, 2022
71335-1858-514 TABLET in 1 BOTTLE, PLASTIC (71335-1858-5)Feb 14, 2022
71335-1858-628 TABLET in 1 BOTTLE, PLASTIC (71335-1858-6)Feb 14, 2022
71335-1858-76 TABLET in 1 BOTTLE, PLASTIC (71335-1858-7)Feb 14, 2022
71335-1858-810 TABLET in 1 BOTTLE, PLASTIC (71335-1858-8)Feb 14, 2022
71335-1858-921 TABLET in 1 BOTTLE, PLASTIC (71335-1858-9)Feb 14, 2022

Other BUPRENORPHINE HYDROCHLORIDE and NALOXONE HYDROCHLORIDE DIHYDRATE products